Cargando…
Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes
Lack of rapid revascularization and inflammatory attacks at the site of transplantation contribute to impaired islet engraftment and suboptimal metabolic control after clinical islet transplantation. In order to overcome these limitations and enhance engraftment and revascularization, we have genera...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842259/ https://www.ncbi.nlm.nih.gov/pubmed/35185372 http://dx.doi.org/10.3389/ti.2021.10214 |